0.658
price down icon1.50%   -0.01
after-market Dopo l'orario di chiusura: .67 0.012 +1.82%
loading

Bolt Biotherapeutics Inc Azioni (BOLT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
152.47%
5.274
2.089 2.528 1.433 1.826
Operating Expenses
2.34%
22.37
21.86 20.71 21.27 20.24
Benefits Costs and Expenses
19.54%
16.09
19.99 - - 18.81
Costs And Expenses
19.54%
16.09
19.99 20.71 21.27 18.81
Operating Income/Loss
13.53%
-17.09
-19.77 -18.18 -19.83 -18.41
Nonoperating Income/Loss
237.14%
6.281
1.863 1.926 1.775 1.435
Income/Loss From Continuing Operations Before Tax
39.61%
-10.81
-17.90 2.528 1.433 -16.98
Income/Loss From Continuing Operations After Tax
39.61%
-10.81
-17.90 -16.26 -18.06 -16.98
Net Income/Loss
39.61%
-10.81
-17.90 -16.26 -18.06 -16.98
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
87,061%
38.07
0.0437 37.87 37.75 37.68
Diluted Average Shares
87,061%
38.07
0.0437 37.87 37.75 37.68
Basic Earnings Per Share
40.43%
-0.28
-0.47 -0.43 -0.48 -0.45
Diluted Earnings Per Share
40.43%
-0.28
-0.47 -0.43 -0.48 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):